MedCity News November 10, 2023
As the industry moves towards more personalized medicine, pharmacogenomics could play a key role in keeping patients healthier longer and in getting them viable treatments for their unique genetic profile.
Clinical trials offer a slew of benefits: optimal dosage ranges, identified potential side effects, and efficacy data. If approved by the FDA, clinicians leverage the insights from Phase III trials to support their patient populations. Yet not all medicines help people equally.
Imagine a set of twins who have a family history of migraines. They both go to the pharmacy and pick up the migraine medication prescribed by the doctor. The prescription works for one twin, but the second still has a migraine. A variety of factors drive such a...
Today's Sponsors
Today's Sponsor